Emily J. Gilmore, MD has been a member of the Division of Neurocritical Care and Emergency Neurology at the Yale School of Medicine and a neurointensivist and critical care EEG attending at Yale-New Haven Hospital in Connecticut since 2012.
Dr. Gilmore completed her neurology residency and 3-year combined fellowship at Columbia University where she fostered a clinical and research interest in neuromonitoring. She was one of the first neurointensivists to become board certified in critical care EEG monitoring and was recruited to Yale to help build a state-of-the art Neuro-ICU where technology could be deployed to deliver cutting edge care for patients with acute brain injury.
Marrying her clinical and research interests was natural; she was an early recipient of the Yale Center for Clinical Investigation (YCCI) Clinical Scholars program and the American Brain Foundation Clinical Research Training Fellowship. She currently serves as the site-PI for several national neurotrauma trials and was recently awarded her first RO1 with colleagues from MGH and UTSW to link the relationship between biomarkers of secondary brain injury, treatment, and outcomes in patients with severe TBI. Her overarching research interests center on understanding and translating physiologic biomarkers obtained from invasive and noninvasive multimodal brain monitoring to individualize care that will improve outcomes for patients with acute brain injury.
Administratively, in addition to her role as Director of the Neuro-ICU and Director of Neuromonitoring, Dr. Gilmore is the co-Director of Neurotrauma. With colleagues in Neurosurgery, she is building a comprehensive multidisciplinary program that addresses the continuum of care needs, from the acute setting though rehabilitation and recovery, for patients with TBI. Additionally, she co-directs the Critical Care EEG program fellowship and program with Dr. Lawrence Hirsch, serves as the chair of the Critical Care EEG Monitoring Research Consortium (CCEMRC) and sits on the scientific advisory board for the NORSE institute.
|Board Member||American Board of Clinical Neurophysiology||2022|